FR2670797A1 - Sequences d'adn determinees derivees du genome du papillomavirus hpv39, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus, et a la production de composition immunogene. - Google Patents

Sequences d'adn determinees derivees du genome du papillomavirus hpv39, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus, et a la production de composition immunogene. Download PDF

Info

Publication number
FR2670797A1
FR2670797A1 FR9016044A FR9016044A FR2670797A1 FR 2670797 A1 FR2670797 A1 FR 2670797A1 FR 9016044 A FR9016044 A FR 9016044A FR 9016044 A FR9016044 A FR 9016044A FR 2670797 A1 FR2670797 A1 FR 2670797A1
Authority
FR
France
Prior art keywords
hpv39
dna
papillomavirus
nucleotide
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR9016044A
Other languages
English (en)
French (fr)
Other versions
FR2670797B1 (https=
Inventor
Orth Gerard
Volpers Christoph
Streeck Rolf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9016044A priority Critical patent/FR2670797A1/fr
Application filed by Institut Pasteur filed Critical Institut Pasteur
Priority to EP92903034A priority patent/EP0563255B1/fr
Priority to JP50307192A priority patent/JP3859696B2/ja
Priority to PCT/FR1991/001053 priority patent/WO1992011369A1/fr
Priority to CA002375673A priority patent/CA2375673C/fr
Priority to DE69104380T priority patent/DE69104380T2/de
Priority to AT92903034T priority patent/ATE112316T1/de
Priority to CA002098819A priority patent/CA2098819C/fr
Priority to ES92903034T priority patent/ES2062887T3/es
Priority to US08/074,879 priority patent/US5656423A/en
Priority to DK92903034.4T priority patent/DK0563255T3/da
Publication of FR2670797A1 publication Critical patent/FR2670797A1/fr
Application granted granted Critical
Publication of FR2670797B1 publication Critical patent/FR2670797B1/fr
Priority to US08/468,057 priority patent/US5665535A/en
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/084—Papillomaviridae (F); Polyomaviridae (F), e.g. SV40, BK virus or JC virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR9016044A 1990-12-20 1990-12-20 Sequences d'adn determinees derivees du genome du papillomavirus hpv39, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus, et a la production de composition immunogene. Granted FR2670797A1 (fr)

Priority Applications (12)

Application Number Priority Date Filing Date Title
FR9016044A FR2670797A1 (fr) 1990-12-20 1990-12-20 Sequences d'adn determinees derivees du genome du papillomavirus hpv39, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus, et a la production de composition immunogene.
ES92903034T ES2062887T3 (es) 1990-12-20 1991-12-20 Secuencias de adn derivadas del genoma del papilomavirus hpv39, su aplicacion al diagnostico in vitro y a la produccion de preparado inmunogeno.
PCT/FR1991/001053 WO1992011369A1 (fr) 1990-12-20 1991-12-20 Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene
CA002375673A CA2375673C (fr) 1990-12-20 1991-12-20 Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene
DE69104380T DE69104380T2 (de) 1990-12-20 1991-12-20 Vom genom des papillomavirus-hpv-39 abgeleitete dns-sequenzen, deren anwendung in der in vitro-diagnose und zur herstellung einer immunogenenzusammensetzung.
AT92903034T ATE112316T1 (de) 1990-12-20 1991-12-20 Vom genom des papillomavirus-hpv-39 abgeleitete dns-sequenzen, deren anwendung in der in vitro- diagnose und zur herstellung einer immunogenenzusammensetzung.
EP92903034A EP0563255B1 (fr) 1990-12-20 1991-12-20 Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene
JP50307192A JP3859696B2 (ja) 1990-12-20 1991-12-20 乳頭腫ウイルスｈｐｖ３９のゲノムから誘導されるｄｎａ配列、ｉｎ ｖｉｔｒｏ診断及び免疫原組成物の生成への前記配列の応用
US08/074,879 US5656423A (en) 1990-12-20 1991-12-20 DNA sequences derived from the genome of the papillomavirus HPV39, their use in in vitro diagnosis and for the production of an immunogenic composition
DK92903034.4T DK0563255T3 (da) 1990-12-20 1991-12-20 DNA-sekvenser afledt af genomet fra papillomavirus HPV39, anvendelse heraf til in vitro-diagnostik og til fremstilling af immunogent præparat
CA002098819A CA2098819C (fr) 1990-12-20 1991-12-20 Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene
US08/468,057 US5665535A (en) 1990-12-20 1995-06-06 Polypeptides encoded by DNA sequences derived from the genome of the papillomavirus HPV39, antibodies thereto, and their use in in vitro diagnosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9016044A FR2670797A1 (fr) 1990-12-20 1990-12-20 Sequences d'adn determinees derivees du genome du papillomavirus hpv39, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus, et a la production de composition immunogene.

Publications (2)

Publication Number Publication Date
FR2670797A1 true FR2670797A1 (fr) 1992-06-26
FR2670797B1 FR2670797B1 (https=) 1994-08-19

Family

ID=9403488

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9016044A Granted FR2670797A1 (fr) 1990-12-20 1990-12-20 Sequences d'adn determinees derivees du genome du papillomavirus hpv39, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus, et a la production de composition immunogene.

Country Status (10)

Country Link
US (2) US5656423A (https=)
EP (1) EP0563255B1 (https=)
JP (1) JP3859696B2 (https=)
AT (1) ATE112316T1 (https=)
CA (2) CA2098819C (https=)
DE (1) DE69104380T2 (https=)
DK (1) DK0563255T3 (https=)
ES (1) ES2062887T3 (https=)
FR (1) FR2670797A1 (https=)
WO (1) WO1992011369A1 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639871A (en) * 1988-09-09 1997-06-17 Roche Molecular Systems, Inc. Detection of human papillomavirus by the polymerase chain reaction
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
MXPA01004287A (es) * 1998-10-26 2002-06-04 Ventana Med Syst Inc Deteccion del virus del papiloma humano en frotis de papanicolau (pap).
US7569344B2 (en) * 1998-10-26 2009-08-04 Ventana Medical Systems, Inc. Detection of human papilloma virus in papanicolaou (Pap) smears
WO2000061804A1 (en) * 1999-04-14 2000-10-19 Musc Foundation For Research Development Tissue-specific and pathogen-specific toxic agents and ribozymes
US20060275784A1 (en) * 1999-10-26 2006-12-07 Ventana Medical Systems, Inc. Detection of Human Papilloma Virus in Papanicolaou (Pap) Smears
US20040229298A1 (en) * 2000-11-11 2004-11-18 Lu Peter S. Methods and compositions for treating cervical cancer
US7312041B2 (en) * 2001-02-16 2007-12-25 Arbor Vita Corporation Methods of diagnosing cervical cancer
EP1417353A4 (en) * 2001-07-20 2005-08-03 Univ Texas METHODS AND COMPOSITIONS ASSOCIATED WITH HPV ASSOCIATED PENCILS AND CANNULAR WELLS, INCLUDING CIN
US7704965B2 (en) * 2002-06-26 2010-04-27 The Penn State Research Foundation Methods and materials for treating human papillomavirus infections
BR0314155A (pt) 2002-09-09 2005-07-05 Arbor Vita Corp Métodos para diagnosticar câncer cervical
WO2005030041A2 (en) 2003-09-25 2005-04-07 Third Wave Technologies, Inc. Detection of hpv
JP5030594B2 (ja) * 2003-12-23 2012-09-19 アルボー ビータ コーポレーション Ｈｐｖの発癌性株に対する抗体およびそれらの使用方法
DE602005022759D1 (de) 2004-12-08 2010-09-16 Gen Probe Inc Nukleinsäuredetektion aus verschiedenen typen des humanen papillomavirus
AU2005313858B2 (en) * 2004-12-10 2011-04-07 Genera Biosystems Limited Human papilloma virus (HPV) detection using nucleic acid probes, microbeads and fluorescent-activated cell sorter (FACS)
US7972776B2 (en) * 2005-11-15 2011-07-05 Oncohealth Corporation Protein chips for HPV detection
US7732166B2 (en) * 2005-11-15 2010-06-08 Oncohealth Corporation Detection method for human pappilomavirus (HPV) and its application in cervical cancer
US8080643B2 (en) * 2006-09-05 2011-12-20 Third Wave Technologies, Inc. HPV primers
US8968995B2 (en) * 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
US20100003704A1 (en) * 2008-06-13 2010-01-07 Shuling Cheng IN SITU detection of early stages and late stages HPV infection
AU2008236678B2 (en) * 2007-04-05 2013-09-12 Genera Biosystems Limited Compositions and methods of detection
GB0820822D0 (en) * 2008-11-13 2008-12-24 Inst Catala D Oncologia Novel product and processes
EP2427763A4 (en) 2009-05-07 2013-08-21 Oncohealth Corp IDENTIFICATION OF A HIGH CIN2 DEGREE FOR THE DETECTION OF EARLY AND LATE TADIES AND FOR THE SCREENING AND DIAGNOSIS OF HUMAN PAPILLOMA (HPV) AND ASSOCIATED CANCER DISORDERS
WO2011084598A1 (en) 2010-01-08 2011-07-14 Oncohealth Corporation High throughput cell-based hpv immunoassays for diagnosis and screening of hpv-associated cancers
JP6153866B2 (ja) * 2010-05-25 2017-06-28 キアゲン ガイサーズバーグ アイエヌシー． 迅速なハイブリッド捕捉アッセイ、及び関連する戦略的に切断されたプローブ

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0235004A2 (fr) * 1986-01-31 1987-09-02 Institut Pasteur Sondes à papillomavirus et procédé de diagnostic in vitro d'infections à papillomavirus
EP0375555A1 (fr) * 1988-12-23 1990-06-27 Medgenix Group, S.A. Peptides, anticorps dirigés contre ces peptides, et procédés de détection et de dosage de papillomavirus HPV16

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2629458B2 (fr) * 1987-07-31 1991-08-09 Ire Celltarg Sa Nouvelles sondes d'acides nucleiques specifiques de differents types de virus de papillome humain
US5182377A (en) * 1988-09-09 1993-01-26 Hoffmann-La Roche Inc. Probes for detection of human papillomavirus
US5447839A (en) * 1988-09-09 1995-09-05 Hoffmann-La Roche Inc. Detection of human papillomavirus by the polymerase chain reaction

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0235004A2 (fr) * 1986-01-31 1987-09-02 Institut Pasteur Sondes à papillomavirus et procédé de diagnostic in vitro d'infections à papillomavirus
EP0375555A1 (fr) * 1988-12-23 1990-06-27 Medgenix Group, S.A. Peptides, anticorps dirigés contre ces peptides, et procédés de détection et de dosage de papillomavirus HPV16

Also Published As

Publication number Publication date
JPH06504672A (ja) 1994-06-02
ES2062887T3 (es) 1994-12-16
JP3859696B2 (ja) 2006-12-20
CA2375673A1 (fr) 1992-07-09
DE69104380D1 (de) 1994-11-03
US5656423A (en) 1997-08-12
WO1992011369A1 (fr) 1992-07-09
ATE112316T1 (de) 1994-10-15
EP0563255A1 (fr) 1993-10-06
CA2098819A1 (fr) 1992-06-21
CA2098819C (fr) 2002-06-18
DK0563255T3 (da) 1994-10-24
EP0563255B1 (fr) 1994-09-28
DE69104380T2 (de) 1995-02-09
US5665535A (en) 1997-09-09
CA2375673C (fr) 2005-05-17
FR2670797B1 (https=) 1994-08-19

Similar Documents

Publication Publication Date Title
EP0563255B1 (fr) Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene
AU615159B2 (en) Determined dna sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions
Donne et al. The role of HPV type in recurrent respiratory papillomatosis
EP0462187B1 (fr) Composition pharmaceutique, utile a titre preventif ou curatif contre les tumeurs induites par les papillomavirus
CA1276575C (fr) Sondes a papillomavirus et procede de diagnostic in vitro d'infections a papillomavirus
EP0342128B1 (fr) Sondes à papillomavirus (HPV49, HPV50, HPV54, HPV55), produits génétiquement et immunologiquement liés à ce papillomavirus et procédé de diagnostic in vitro d'infection à papillomavirus et de production d'anticorps contre ces papillomavirus
JP4505452B2 (ja) 酵母におけるｈｐｖ３１ｌ１の最適化発現
Mossadegh et al. Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells
JP2004000269A (ja) パピローマウイルスワクチン
Iftner et al. Transcription of the E6 and E7 genes of human papillomavirus type 6 in anogenital condylomata is restricted to undifferentiated cell layers of the epithelium
CA1279276C (fr) Polypeptides et anticorps, caracteristiques du papillomavirus et leurs applications au diagnostic in vitro a la prevention et/ou la lutte contre des infections a papillomavirus
EP0591376B1 (fr) Sequences adn du papillomavirus hpv42: application au diagnostic
US6290965B1 (en) DNA encoding human papillomavirus type 6A
US6395512B1 (en) DNA coding for a peptide of a papilloma virus main capside protein and use thereof
FR2593828A2 (fr) Sonde a papillomavirus et procede de diagnostic in-vitro d'infections a papillomavirus
US6562597B2 (en) Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses
EP0458668A1 (fr) Sonde à papillomavirus (HPV66), notamment pour le diagnostic in vitro d'infections à papillomavirus, pouvant s'accompagner de néoplasies génitales, et produits génétiquement et immunologiquement liés à ce papillomavirus
WO1991009866A1 (fr) Sonde a papillomavirus (hpv63), notamment pour le diagnostic in vitro d'infections a papillomavirus, pouvant s'accompagner de neoplasies genitales, et produits genetiquement et immunologiquement lies a ce papillomavirus
HPV34 et al. Group B Sequences
FR2631341A1 (fr) Sondes a papillomavirus hpv49, hpv50, hpv54, hpv55 et produits genetiquement et immunologiquement lies a ce papillomavirus hpv49, hpv50, hpv54, hpv55 et procede de diagnostic in vitro d'infections a papillomavirus et d'immunisation in vivo contre ces papillomavirus
Li Expression and characterization of the human papillomavirus type 6b open reading frame proteins
NUCLEIC Departments of Pathology and OB/GYN

Legal Events

Date Code Title Description
TP Transmission of property